DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document DBV Technologies (Euronext: ...

Dataome curates, integrates and structures molecular, phenotypic and clinical data from public, private and proprietary ...

According to the Korea Health Industry Promotion Agency on the 4th, pharmaceutical exports in the first quarter reached $2.56 ...

The biopharmaceutical sector is underpinned by a unique ecosystem that combines public funding for basic research, university ...

Sun Pharma Advanced Research Company (SPARC) shares plummeted nearly 20% after its psoriasis drug, SCD-044, failed to meet primary endpoints in Phase 2 trials.

Thermo Fisher Scientific launched two advanced mass spectrometers and emphasized its multi-omics strategy during the American ...

Trethera Corporation ("Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer ...

Shares of Sun Pharma Advanced Research Company (SPARC) shares crashed significantly on Wednesday after the company announced ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

B. Riley raised Kymera Therapeutics, Inc.’s (NASDAQ:KYMR) price target from $38 to $60, upgrading it from Neutral to Buy on ...

Shares of Sun Pharma Advanced Research Company (SPARC), the research division of India’s largest pharmaceutical firm Sun Pharma, fell 19 per cent to Rs 158 each after unsatisfactory Phase 2 trial ...